European journal of heart failure · 2026
Liver-related outcomes in patients with tricuspid regurgitation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Jingnan, Huang Jiayi, Guo Ran, Gu Wenli, Xuan Haochen, Liu Lin, Chen Guihua, Guo Shi-Tian, Wang Chenxu, Matsumoto Ami, Zhu Ching-Yan, Chu Sun-Nam, Shi Yueran, Chan Yap-Hang, Ren Qingwen, Yiu Kai-Hang
Аннотация
AIMS: The natural history of hepatic involvement in tricuspid regurgitation (TR) remains undercharacterized. We aimed to assess the incidence and risk of liver-related outcomes associated with TR severity and to identify the predictors and survival impact of cirrhosis in patients with ≥moderate TR.
METHODS: From 2004 to 2022, adults with documented TR severity were retrospectively included. Liver-related outcomes including cirrhosis, hepatocellular carcinoma (HCC), and liver-related death were followed longitudinally.
RESULTS: Among 41 950 patients without prevalent liver disease, 7226 (17.3%) had ≥moderate TR. The median follow-up was 6.4 years. Incidence rates of cirrhosis, HCC and liver-related death in patients with ≥moderate TR were 4.54 [95% confidence interval (CI), 3.89-5.29], 1.25 (95% CI, 0.92-1.68), and 1.33 (95% CI, 0.99-1.77) per 1000 person-years, respectively. Compared with no/trace TR, both moderate and severe TR were associated with an increased risk of cirrhosis, while risks of HCC and liver-related death did not differ statistically across TR severity groups. Among patients with ≥moderate TR, independent predictors of cirrhosis were heart failure with preserved ejection fraction, right ventricular dysfunction, and cholestatic liver injury. Ventricular TR [hazard ratio (HR): 2.33, 95% CI, 1.22-4.43, P = .009] and lead-associated TR (HR: 2.66, 95% CI, 1.16-6.09, P = .02) were associated with a higher risk of cirrhosis than atrial TR. Incident cirrhosis increased all-cause and cardiovascular death risks in patients with ≥moderate TR.
CONCLUSIONS: Significant TR is associated with incident cirrhosis, with risk varying by aetiology. The development of cirrhosis portends a worse survival, supporting more comprehensive hepatic evaluation during TR management.
METHODS: From 2004 to 2022, adults with documented TR severity were retrospectively included. Liver-related outcomes including cirrhosis, hepatocellular carcinoma (HCC), and liver-related death were followed longitudinally.
RESULTS: Among 41 950 patients without prevalent liver disease, 7226 (17.3%) had ≥moderate TR. The median follow-up was 6.4 years. Incidence rates of cirrhosis, HCC and liver-related death in patients with ≥moderate TR were 4.54 [95% confidence interval (CI), 3.89-5.29], 1.25 (95% CI, 0.92-1.68), and 1.33 (95% CI, 0.99-1.77) per 1000 person-years, respectively. Compared with no/trace TR, both moderate and severe TR were associated with an increased risk of cirrhosis, while risks of HCC and liver-related death did not differ statistically across TR severity groups. Among patients with ≥moderate TR, independent predictors of cirrhosis were heart failure with preserved ejection fraction, right ventricular dysfunction, and cholestatic liver injury. Ventricular TR [hazard ratio (HR): 2.33, 95% CI, 1.22-4.43, P = .009] and lead-associated TR (HR: 2.66, 95% CI, 1.16-6.09, P = .02) were associated with a higher risk of cirrhosis than atrial TR. Incident cirrhosis increased all-cause and cardiovascular death risks in patients with ≥moderate TR.
CONCLUSIONS: Significant TR is associated with incident cirrhosis, with risk varying by aetiology. The development of cirrhosis portends a worse survival, supporting more comprehensive hepatic evaluation during TR management.